US Drug Recall Register
Class I · High risk Terminated Initiated Oct 2, 2023 (3 years ago)

4.2% Sodium Bicarbonate Injection

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: identified as glass.

What was recalled

4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-5534-24

Recalling firm
Pfizer Inc.
NDC code
0409-5534-24
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0100-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Bicarbonate recalls

See all
Class II · Moderate risk Ongoing

4.2% Sodium Bicarbonate Injection

Reason Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.

Exela Pharma Sciences LLC NDC 51754-5012-1 D-0620-2025
Class I · High risk Ongoing

SinuCleanse Soft Tip NETI POT Nasal Wash System

Reason Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus

Ascent Consumer Products Inc. D-0301-2025
Class I · High risk Ongoing

SinuCleanse Premixed SALINE PACKETS

Reason Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus

Ascent Consumer Products Inc. D-0300-2025